Barclays Maintains Overweight on Stryker, Lowers Price Target to $365
Benzinga Newsdesk 23 hours ago
Analyst RatingsNewsPrice TargetHot
Barclays analyst Christopher Pasquale maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $375 to $365.
Barclays analyst Christopher Pasquale maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $375 to $365.